ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05213	Endometrial cancer	1/2	62/7206	0.0171350384049
ko05221	Acute myeloid leukemia	1/2	63/7206	0.017410196569
ko05223	Non-small cell lung cancer	1/2	66/7206	0.0182354399325
ko05014	Amyotrophic lateral sclerosis (ALS)	1/2	74/7206	0.0204343939616
ko01524	Platinum drug resistance	1/2	76/7206	0.0209837472553
ko04370	VEGF signaling pathway	1/2	77/7206	0.0212583661201
ko05212	Pancreatic cancer	1/2	83/7206	0.0229052703599
ko05220	Chronic myeloid leukemia	1/2	85/7206	0.0234539302686
ko05218	Melanoma	1/2	85/7206	0.0234539302686
ko05210	Colorectal cancer	1/2	86/7206	0.0237282024407
ko01521	EGFR tyrosine kinase inhibitor resistance	1/2	106/7206	0.0292055564002
ko04012	ErbB signaling pathway	1/2	109/7206	0.0300258305066
ko05215	Prostate cancer	1/2	111/7206	0.0305724873041
ko01522	Endocrine resistance	1/2	124/7206	0.0341220006542
ko05145	Toxoplasmosis	1/2	126/7206	0.0346675018105
ko04919	Thyroid hormone signaling pathway	1/2	143/7206	0.0392980404373
ko04142	Lysosome	1/2	151/7206	0.0414732653006
ko05160	Hepatitis C	1/2	153/7206	0.0420166863035
ko04722	Neurotrophin signaling pathway	1/2	160/7206	0.0439174463882
ko04140	Autophagy - animal	1/2	164/7206	0.0450027475377
ko04910	Insulin signaling pathway	1/2	172/7206	0.0471715008106
ko05161	Hepatitis B	1/2	173/7206	0.0474424216231
ko04210	Apoptosis	1/2	180/7206	0.0493377887158